Literature DB >> 16684821

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Jaakko Perheentupa1.   

Abstract

CONTEXT: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy is known as a rare hereditary disease with classic triad of mucocutaneous candidiasis, hypoparathyroidism, and adrenocortical failure, two of which, diagnostic dyad, are required for the diagnosis. Evidently many patients suffer unrecognized because the condition is more variable and complex.
OBJECTIVE: The objective of the study was to describe the variability of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy for promoting recognition and adequate follow-up of patients.
SETTING: The Finnish series of patients is the largest internationally. PATIENTS: The study population was all 91 known Finnish patients.
RESULTS: Besides the classical triad, a dozen autoimmune endocrine and other components occurred variably, several of them dangerous. The initial manifestation appeared within the age range of 0.2-18 yr, mucocutaneous candidiasis being part of it in 60% of the patients, hypoparathyroidism in 32%, and adrenocortical failure in 5%. But 23% of the patients had one to six other components before the diagnostic dyad: hepatitis, keratoconjunctivitis, chronic diarrhea, periodic rash with fever. The dyad appeared 0.2-20 yr later. Prevalence of most components increased with age, diabetes mellitus, hypothyroidism, and testicular failure becoming common toward middle age. Tubulointerstitial nephritis occurred in 9% of the patients, apparent mineralocorticoid excess in 9%, asplenia in 19% of adults, and oral or esophageal squamous cell carcinoma in 10% of patients older than 25 yr.
CONCLUSIONS: Any child or young adult with one of the many disease components should be examined for others and consideration of AIRE mutation assay.

Entities:  

Mesh:

Year:  2006        PMID: 16684821     DOI: 10.1210/jc.2005-2611

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  141 in total

1.  Hypoparathyroidism and central diabetes insipidus: in search of the link.

Authors:  Ori Eyal; Asaf Oren; Harald Jüppner; Raz Somech; Annamaria De Bellis; Michael Mannstadt; Auryan Szalat; Margalit Bleiberg; Yosef Weisman; Naomi Weintrob
Journal:  Eur J Pediatr       Date:  2014-11-04       Impact factor: 3.183

2.  High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study.

Authors:  D Capalbo; A Fusco; G Aloj; N Improda; L Vitiello; U Dianzani; C Betterle; M Salerno; C Pignata
Journal:  J Endocrinol Invest       Date:  2011-11-07       Impact factor: 4.256

3.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

4.  A novel mutation in autoimmune regulator gene causes autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Ping Jin; Qin Zhang; Chang-Sheng Dong; Shao-Li Zhao; Zhao-Hui Mo
Journal:  J Endocrinol Invest       Date:  2014-07-27       Impact factor: 4.256

5.  [Clinical analysis and autoimmune regulator gene mutation of autoimmune polyendocrinopathy syndrome type I in a family: a report of one case].

Authors:  Yong-Xiang Sun; Ya-Fei He; Xia-Lian Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-02

6.  Autoimmunity's collateral damage: Immunodeficiency hints at autoreactivity to cytokines.

Authors:  Michael Waterfield; Mark S Anderson
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

Review 7.  T cells in the control of organ-specific autoimmunity.

Authors:  Jeffrey A Bluestone; Hélène Bour-Jordan; Mickie Cheng; Mark Anderson
Journal:  J Clin Invest       Date:  2015-05-18       Impact factor: 14.808

8.  A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

Authors:  Li Zhang; Jennifer M Barker; Sunanda Babu; Maureen Su; Matthew Stenerson; Mickie Cheng; Anthony Shum; Ehud Zamir; Raffaele Badolato; Adam Law; George S Eisenbarth; Mark S Anderson
Journal:  Clin Immunol       Date:  2007-09-06       Impact factor: 3.969

9.  Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1.

Authors:  E Helen Kemp; Nikos G Gavalas; Kai J E Krohn; Edward M Brown; Philip F Watson; Anthony P Weetman
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

10.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.